Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick P J Phillips

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Statistics in Medicine|July 7, 2015
Comments on 'A modest proposal for dropping poor arms in clinical trials' by Proschan and DoddDaniel J Bratton, Babak Choodari-Oskooei, Patrick P J Phillips, et al.
JAMA Network Open|June 7, 2024
Validation of a Handheld 6-Lead Device for QT Interval Monitoring in Resource-Limited SettingsJohn Z Metcalfe, Tamsin Economou, Fahd Naufal, et al.
Plos Medicine|March 23, 2019
Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscapePatrick P J Phillips, Carole D Mitnick, James D Neaton, et al.
Contemporary Clinical Trials|July 11, 2025
Designing a response-over-continuous-intervention (ROCI) randomised trial: Implementation in the Phase 2C part (duration ranging) of the PARADIGM4TB trialTra My Pham, Angela M Crook, Katie Rolfe, et al.
BMJ Open|October 3, 2019
Proposals on Kaplan-Meier plots in medical research and a survey of stakeholder views: KMunicateTim P Morris, Christopher I Jarvis, William Cragg, et al.
American Journal of Respiratory and Critical Care Medicine|November 13, 2019
Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical ModelingJason E Stout, Nicholas A Turner, Robert W Belknap, et al.
American Journal of Respiratory and Critical Care Medicine|April 14, 2020
Reply to Swindells <i>et al.</i>: Trials of Tuberculosis-Preventive Therapy in People with HIV InfectionJason E Stout, Nicholas A Turner, Robert W Belknap, et al.
Journal of Proteome Research|April 15, 2026
Longitudinal Plasma Proteomic Profiling Reveals Divergent Immune Responses in Durably Cured and Relapsed Pulmonary TuberculosisDaniel H Call, Le Z Day, Patrick P J Phillips, et al.
BMC Medicine|November 25, 2017
A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimensPatrick P J Phillips, Carl M Mendel, Andrew J Nunn, et al.
Trials|May 13, 2022
Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trialFred C Semitala, Lelia H Chaisson, David W Dowdy, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Statistics in Medicine|July 7, 2015
Comments on 'A modest proposal for dropping poor arms in clinical trials' by Proschan and DoddDaniel J Bratton, Babak Choodari-Oskooei, Patrick P J Phillips, et al.
JAMA Network Open|June 7, 2024
Validation of a Handheld 6-Lead Device for QT Interval Monitoring in Resource-Limited SettingsJohn Z Metcalfe, Tamsin Economou, Fahd Naufal, et al.
Plos Medicine|March 23, 2019
Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscapePatrick P J Phillips, Carole D Mitnick, James D Neaton, et al.
Contemporary Clinical Trials|July 11, 2025
Designing a response-over-continuous-intervention (ROCI) randomised trial: Implementation in the Phase 2C part (duration ranging) of the PARADIGM4TB trialTra My Pham, Angela M Crook, Katie Rolfe, et al.
BMJ Open|October 3, 2019
Proposals on Kaplan-Meier plots in medical research and a survey of stakeholder views: KMunicateTim P Morris, Christopher I Jarvis, William Cragg, et al.
American Journal of Respiratory and Critical Care Medicine|November 13, 2019
Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical ModelingJason E Stout, Nicholas A Turner, Robert W Belknap, et al.
American Journal of Respiratory and Critical Care Medicine|April 14, 2020
Reply to Swindells <i>et al.</i>: Trials of Tuberculosis-Preventive Therapy in People with HIV InfectionJason E Stout, Nicholas A Turner, Robert W Belknap, et al.
Journal of Proteome Research|April 15, 2026
Longitudinal Plasma Proteomic Profiling Reveals Divergent Immune Responses in Durably Cured and Relapsed Pulmonary TuberculosisDaniel H Call, Le Z Day, Patrick P J Phillips, et al.
BMC Medicine|November 25, 2017
A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimensPatrick P J Phillips, Carl M Mendel, Andrew J Nunn, et al.
Trials|May 13, 2022
Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trialFred C Semitala, Lelia H Chaisson, David W Dowdy, et al.
Pageof 12